Three functional variants of IFN regulatory factor 5 ( <i>IRF5</i> ) define risk and protective haplotypes for human lupus

Robert Graham(Broad Institute), Chieko Kyogoku(University of Minnesota Medical Center), Snævar Sigurðsson(Uppsala University), Irina Vlasova-St. Louis(University of Minnesota Medical Center), Leela Davies(Broad Institute), Emily C. Baechler(Autoimmune Technologies (United States)), Robert M. Plenge(Broad Institute), Thearith Koeuth(University of Minnesota Medical Center), Ward Ortmann(University of Minnesota Medical Center), Geoffrey Hom(University of Minnesota Medical Center), Jason W. Bauer(University of Minnesota Medical Center), Clarence Gillett(University of Minnesota Medical Center), Noël P. Burtt(Broad Institute), Deborah S. Cunninghame Graham(Hammersmith Hospital), Robert C. Onofrio(Broad Institute), Michelle Petri(Johns Hopkins University), Iva Gunnarsson(Karolinska University Hospital), Elisabet Svenungsson(Karolinska University Hospital), Lars Rönnblom(Uppsala University), Gunnel Nordmark(Uppsala University), Peter K. Gregersen(Northwell Health), Kathy L. Moser(University of Minnesota Medical Center), Patrick M. Gaffney(University of Minnesota Medical Center), Lindsey A. Criswell(University of California, San Francisco), Timothy J. Vyse(Hammersmith Hospital), Ann-Christine Syvänen(Uppsala University), Paul R. Bohjanen(University of Minnesota Medical Center), Mark J. Daly(Broad Institute), Timothy W. Behrens(University of Minnesota Medical Center), David Altshuler(Broad Institute)
Proceedings of the National Academy of Sciences
April 6, 2007
Cited by 455Open Access
Full Text

Abstract

Systematic genome-wide studies to map genomic regions associated with human diseases are becoming more practical. Increasingly, efforts will be focused on the identification of the specific functional variants responsible for the disease. The challenges of identifying causal variants include the need for complete ascertainment of genetic variants and the need to consider the possibility of multiple causal alleles. We recently reported that risk of systemic lupus erythematosus (SLE) is strongly associated with a common SNP in IFN regulatory factor 5 (IRF5), and that this variant altered spicing in a way that might provide a functional explanation for the reproducible association to SLE risk. Here, by resequencing and genotyping in patients with SLE, we find evidence for three functional alleles of IRF5: the previously described exon 1B splice site variant, a 30-bp in-frame insertion/deletion variant of exon 6 that alters a proline-, glutamic acid-, serine- and threonine-rich domain region, and a variant in a conserved polyA+ signal sequence that alters the length of the 3' UTR and stability of IRF5 mRNAs. Haplotypes of these three variants define at least three distinct levels of risk to SLE. Understanding how combinations of variants influence IRF5 function may offer etiological and therapeutic insights in SLE; more generally, IRF5 and SLE illustrates how multiple common variants of the same gene can together influence risk of common disease.


Related Papers

No related papers found

Powered by citation graph analysis